NeutriSci International Inc. (NRXCF)

0.0557 0.0000 (0.00%) At close: 09:30AM EST

NeutriSci International Inc.

609 Granville Street
Suite 1600
Vancouver, BC V7Y 1C3
Canada

https://www.neutrisci.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Glen Rehman	CEO, Pres & Director	127.85k	N/A	N/A
Mr. John Robert Chisholm	Chief Financial Officer	N/A	N/A	1962
Ms. Jaycee Waters	Operations & Logistics Mang.	N/A	N/A	N/A
Mr. Thierry Sorhaitz	VP of Sales & Marketing	N/A	N/A	N/A

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation, LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Corporate Governance

NeutriSci International Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.